Description
A potent inhibitor of PI3K isoforms (Kis = 19, 130, 24, and 60 pM for p110α, β, δ, and γ, respectively); also inhibits mTOR in both mTORC1 and mTORC2 (Kis = 180 and 300 nM, respectively); orally bioavailable, displays favorable pharmacokinetics, and shows efficacy in tumor growth models,
Formal name: 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-benzenesulfonamide
Synonyms: GSK458|Omipalisib
Molecular weight: 505.5
CAS: 1086062-66-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|mTOR||Product Type|Biochemicals|Kinase Inhibitors|PI3K||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling